ArticlePDF Available

Association Between Periodontitis Needing Surgical Treatment and Subsequent Diabetes Risk: A Population-Based Cohort Study

Authors:

Abstract and Figures

Background: It is well known that patients with diabetes have higher extent and severity of periodontitis, but the backward relationship is little investigated. The relationship between periodontitis needing dental surgery and subsequent type 2 diabetes mellitus (DMT2) in those individuals without diabetes was assessed. Methods: This is a retrospective cohort study using data from the national health insurance system of Taiwan. The periodontitis cohort involved 22,299 patients, excluding those with diabetes already or those diagnosed with diabetes within 1 year from baseline. Each study participant was randomly frequency matched by age, sex, and index year with one individual from the general population without periodontitis. Cox proportional hazards regression analysis was used to estimate the influence of periodontitis on the risk of diabetes. Results: The mean follow-up period is 5.47 ± 3.54 years. Overall, the subsequent incidence of DMT2 was 1.24-fold higher in the periodontitis cohort than in the control cohort, with an adjusted hazard ratio of 1.19 (95% confidence interval = 1.10 to 1.29) after controlling for sex, age, and comorbidities. Conclusions: This is the largest nation-based study examining the risk of diabetes in Asian patients with periodontitis. Those patients with periodontitis needing dental surgery have increased risk of future diabetes within 2 years compared with those participants with periodontitis not requiring dental surgery.
Content may be subject to copyright.
Association Between Periodontitis
Needing Surgical Treatment and
Subsequent Diabetes Risk: A
Population-Based Cohort Study
Shih-Yi Lin,*
†‡
Cheng-Li Lin,
§i
Jiung-Hsiun Liu,
†‡
I-Kuan Wang,*
†‡
Wu-Huei Hsu,*
Chao-Jung Chen,
¶#
I-Wen Ting,
†‡
I-Ting Wu,** Fung-Chang Sung,
§i
Chiu-Ching Huang,*
†‡
and Yen-Jung Chang
††
Background: It is well known that patients with diabetes
have higher extent and severity of periodontitis, but the
backward relationship is little investigated. The relationship
between periodontitis needing dental surgery and subse-
quent type 2 diabetes mellitus (DMT2) in those individuals
without diabetes was assessed.
Methods: This is a retrospective cohort study using data
from the national health insurance system of Taiwan. The
periodontitis cohort involved 22,299 patients, excluding
those with diabetes already or those diagnosed with diabetes
within 1 year from baseline. Each study participant was ran-
domly frequency matched by age, sex, and index year with
one individual from the general population without peri-
odontitis. Cox proportional hazards regression analysis was
used to estimate the influence of periodontitis on the risk of
diabetes.
Results: The mean follow-up period is 5.47 3.54 years.
Overall, the subsequent incidence of DMT2 was 1.24-fold
higher in the periodontitis cohort than in the control cohort,
with an adjusted hazard ratio of 1.19 (95% confidence inter-
val =1.10 to 1.29) after controlling for sex, age, and comor-
bidities.
Conclusions: This is the largest nation-based study exam-
ining the risk of diabetes in Asian patients with periodontitis.
Those patients with periodontitis needing dental surgery
have increased risk of future diabetes within 2 years com-
pared with those participants with periodontitis not requiring
dental surgery. J Periodontol 2014;85:779-786.
KEY WORDS
Diabetes mellitus, type 2; periodontitis; retrospective
studies.
Type 2 diabetes mellitus (DMT2) is
a major global health concern.
The prevalence of diabetes is
increasing rapidly, not only in the in-
dustrialized countries but also in
low-middle income countries.
1,2
The
pathogenesis of DMT2 involves a com-
plicated genetic–environmental interac-
tion. Family history, ethnicity, age, and
obesity might play contributing roles.
3,4
Along with the pathologic process, in-
sulin resistance accompanied by b-cell
dysfunction ensues and is the critical
determinant of developing glucose in-
tolerance and diabetes.
5
Chronic low-
grade inflammation has been proposed
to be the link between insulin resistance,
metabolic syndrome, and DMT2.
6
Stud-
ies have investigated the pathogenic
role of inflammatory mediators, such as
tumor necrosis factor (TNF)-alpha and
interleukin (IL)-6, in the development
of diabetes.
7-9
However, not many
researchers have investigated the as-
sociation between the clinical condition
of chronic inflammation and incident
diabetes.
Periodontitis, a common but complex
disease, manifests chronic infection and
inflammation of the supporting tissues
of the teeth.
10
The effects of periodontitis
might be systemic, rather than being
limited to the teeth and periodontium
* Institute of Clinical Medical Science, China Medical University College of Medicine,
Taichung, Taiwan.
Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Division of Nephrology and Kidney Institute, China Medical University Hospital.
§ Management Office for Health Data, China Medical University Hospital.
iDepartment of Public Health, China Medical University, Taichung, Taiwan.
Graduate Institute of Integrated Medicine, China Medical University.
# Proteomics Core Laboratory, Department of Medical Research, China Medical University
Hospital.
** Department of Dentistry, China Medical University Hospital.
†† Department of Health Promotion and Health Education, National Taiwan Normal
University, Taipei, Taiwan. doi: 10.1902/jop.2013.130357
779
J Periodontol June 2014
only.
11
Therefore, periodontitis might provide a
clinical model to investigate the possible role of
chronic inflammation on health. Periodontitis has
been reported to be associated with strokes and
rheumatoid arthritis.
12,13
Until now, two studies
have attempted to demonstrate an association be-
tween periodontitis and incident diabetes.
14,15
Demmer et al.
14
have reported baseline periodontal
disease as an independent predictor of future di-
abetes in the US population, but the results are
limited because of the inability to exclude un-
diagnosed diabetes at baseline. In a study of Jap-
anese adults, Ide et al.
15
did not find a significant
association between periodontitis and DMT2. Be-
cause periodontitis is common worldwide, knowing
its relationship with glucose homeostasis is impor-
tant for public health management. Moreover, it has
been shown that early detection of glucose in-
tolerance or DMT2 improves the clinical outcome
through lifestyle intervention or pharmacotherapy.
16
DMT2 is an increasing epidemic in Asia.
2
In light of
uncertainties regarding the association of peri-
odontitis and incident diabetes, nation-based in-
surance claims data were used to investigate the
risk of incident diabetes in an Asian diabetic-free
cohort with periodontitis.
MATERIALS AND METHODS
Data Sources
The Taiwan Department of Health integrated 13
health insurance schemes into a universal insurance
program in March 1995. This insurance program has
covered 99% of the total 23.74 million citizens and
contracted with 97% of hospitals and clinics in
Taiwan.
17
The National Health Research Institute
has computerized medical claims and selected sets
of health care data for administrative use and research
with information on the basic patient demographic
status, disease codes, health care rendered, medi-
cations prescribed, admissions, discharges, medical
institutions, and physicians providing the services,
etc. The scrambled identifications secured the
patients’ confidentiality. Thus, this study is ex-
empted from ethics review. The present study data
comes from a database containing complete
medical claims for 1 million people randomly
sampled from the entire insured population. No
significant differences exist in the age, sex, and
insured amount distributions among patients in
this selected database and the original National
Health Insurance Research Database (NHIRD).
This database was used to follow the study cohort
over time. Codes of the International Classification
of Diseases, Ninth Revision, Clinical Modification
(ICD-9-CM) were applied to retrieve information on
diagnosis.
Study Participants
Adult patients aged 40 years were enrolled with
periodontal disease based on claims data (ICD-9-CM
codes 523.4 and 523.5) from January 1, 1997 to
December 31, 2009. To ensure the accuracy and
severity of periodontitis, those who underwent peri-
odontal surgery including subgingival curettage
(procedure codes 91006C, 91007C, and 91008C)
and periodontal flap procedure (procedure codes
91009C and 91010C) were selected as the severe
periodontitis cohort. A comparison cohort was se-
lected randomly from those with periodontitis who
did not receive periodontal surgery. The index date
was defined as the date the periodontal surgery was
received. The index date was designated time t
0
, the
first year time t
1
, the second year time t
2
, and an-
nually thereafter (time t
n
). All patients with type 1
diabetes or DMT2 diagnosed before the index date
or any diabetes recorded between time t
0
and time
t
1
were excluded. The control cohort was matched
with the study cohort at a ratio of 1:1 and matched
by sex, age, and index year using the same exclu-
sion criteria. The proportionality assumption based
on the Schoenfeld residuals was tested and found
that the assumption was violated. In the subsequent
analyses, the follow-up period and fitted separate
models were stratified.
Outcome Measures
The primary outcome is the development of DMT2,
which was determined as patients who have been
diagnosed with ICD-9-CM codes 250 at least two
times and concomitantly received antidiabetes
medications. Each study participant was followed
until DMT2 (ICD-9-CM code 250 and who received
antidiabetes agents) was diagnosed or until the time
the participant was censored for loss to follow-up,
death, termination of insurance, or by the end of
follow-up, December 31, 2010. Participants with
hypertension (ICD-9-CM codes 401 to 405), hyper-
lipidemia (ICD-9-CM code 272), coronary artery
disease (ICD-9-CM codes 410 to 414), and obesity
(ICD-9-CM codes 278.00 to 278.01) identified before
the index date were considered as comorbidities.
Statistical Analyses
Statistical software
‡‡
was used for all statistical
analyses. The x
2
test for categorical variables and t
test for continuous variables were used to examine
the difference in the distributions of sociodemo-
graphic and comorbidities between the study and the
comparison cohort.
Cox proportional hazards regression analysis
was used to estimate the risk of diabetes in associ-
ation with periodontitis. The follow-up period was
‡‡ SAS v.9.1 for Windows, SAS Institute, Cary, NC.
780
Periodontitis and Risk of Diabetes Volume 85 Number 6
partitioned into four segments: 1) within 2 years
(time t
1
to t
3
), 2) 3 to 5 years (time t
4
to t
6
), 3) 6 to 8
years (time t
7
to t
9
), and 4) >8 years (time t
9
to t
n
).
The Poisson regression model was used to examine
how the incidence density rates, the incidence rate
ratio (IRR), and 95% confidence intervals (CIs) of
DMT2 differed for categorical variables or over time.
The event-free survival functions for incident di-
abetes between two cohorts were assessed using the
Kaplan–Meier method, and the log-rank test was
used to examine the difference. All significant levels
were set at a two-tailed Pvalue.
RESULTS
The mean follow-up period is 5.47 3.54 years. The
periodontitis cohort included 22,299 participants,
and the non-periodontitis cohort involved 22,302
participants during the period from 1997 to 2010
(Table 1). The severe periodontitis and comparison
cohorts were similar in distributions of age and sex,
with a mean age of 53.0 years. The dominant sex was
male (51.8%). The severe periodontitis cohort was
more prevalent with comorbidities, including hy-
pertension, hyperlipidemia, coronary artery disease
(CAD), and obesity (all Pvalues <0.05). The in-
cidence of diabetes was 1.24-fold higher in the severe
periodontitis cohort than in the comparison cohort
(11.3 versus 9.16 per 1,000 person-years), with an
adjusted hazard ratio (HR) of 1.19 (95% CI =1.10 to
1.29; Table 2). The IRR of diabetes was higher for
males than females. Generally, the incidence of di-
abetes increased with age in both cohorts. However,
the age-specific analysis showed that the IRR of
DMT2 is younger in the severe periodontitis cohort
than the control cohort. The adjusted HRs showed
that age, income, hypertension, and hyperlipidemia
were significant risk factors for DMT2.
Table 3 shows that the incidence of DMT2 in the se-
vere periodontitis cohort decreased with follow-up year,
whereas that in the comparison cohort was increasing.
The severe periodontitis cohort
to the comparison cohort IRR
was the highest in the earlier
period,fromtimet
1
to time t
3
(12.7 versus 9.82 per 1,000
person-years), with an ad-
justed HR of 1.23. The elevated
risk disappeared after being
followed up for 6 years. The
cumulative incidence of diabe-
tes was higher in the severe
periodontitis cohort than the
comparison cohort during the
entire follow-up period (log-
rank test, P<0.001; Fig. 1).
DISCUSSION
In this population-based co-
hort study, the association
between periodontitis and
risk of diabetes was con-
firmed. In both cohorts, the
incidence of diabetes in-
creased with age. Participants
with comorbidities of hyper-
tension, hyperlipidemia, and
lower income at baseline are
associated with increased risk
of incident diabetes. More-
over, increased risk of de-
veloping diabetes associated
with severe periodontitis is
observed from time t
1
to time
t
3
after the periodontal sur-
gery. Although the elevated
risk disappeared after being
Ta b l e 1 .
Baseline Characteristics Between Periodontitis Cohorts With
and Without Surgical Treatment in from 1997 to 2010
Periodontitis Needing Surgical Treatment
No (N =22,302) Yes (N =22,299) Pvalue
Age, mean SD (years) 53.0 9.69 53.0 9.60 0.98
Stratified age (years)
40 to 64 19,030 (85.3) 19,062 (85.5) 0.64*
65 3,272 (14.7) 3,237 (14.5)
Sex
Females 10,759 (48.2) 10,759 (48.3) 0.99*
Males 11,543 (51.8) 11,540 (51.8)
Urbanization
1 (highest) 6,611 (29.6) 8,621 (38.7) <0.001*
2 6,661 (29.9) 6,808 (30.5)
3 4,016 (18.0) 3,583 (16.1)
4 (lowest) 5,014 (22.5) 3,286 (14.7)
Income (NT$)
<15,840 5,165 (23.2) 4,894 (22.0) <0.001*
15,841 to 25,000 11,075 (49.7) 8,551 (38.4)
>25,000 6,062 (27.2) 8,854 (39.7)
Comorbidity
Hypertension 5,432 (24.4) 5,674 (25.5) 0.008*
Hyperlipidemia 3,381 (15.2) 4,361 (19.6) <0.001*
CAD 2,303 (10.3) 2,810 (12.6) <0.001*
Obesity 193 (0.87) 269 (1.21) <0.001*
CAD =coronary artery disease.
Data are presented as n (%) unless otherwise noted. Data for Urbanization representing ‘‘Yes’’ cohorts had one
patient with missing information in totals.
*x
2
test.
† Two-sample ttest.
‡ NT$ =New Taiwan dollars per month. One New Taiwan dollar =US $0.03.
J Periodontol June 2014 Lin, Lin, Liu et al.
781
followed up for 6 years, the cumulative incidence of
diabetes remained significantly higher in the severe
periodontitis cohort than the comparison cohort during
the entire follow-up period. The above finding suggests
that those patients with periodontitis requiring dental
surgery might have a higher risk of developing diabetes
within 3 years than those patients with periodontitis
who needed no surgery treatment.
Ample clinical studies have established a well-
described bidirectional relationship between diabetes
and periodontitis: patients with diabetes tend to have
periodontitis, and the severity of periodontitis would
influence the glycemic control in established di-
abetes.
18-20
Up to the present, only two clinical
studies have evaluated the risk of incident diabetes in
individuals with periodontitis.
14,15
However, the two
Table 2.
Incidence and Adjusted HR of Diabetes Adjusted by Sex, Age, Urbanization, Income, and
Comorbidity Compared Between Periodontitis Cohorts With and Without Surgical
Treatment
Periodontitis Needing Surgical Treatment
No Yes
Cases Person-Years Rate*Cases Person-Years Rate*IRR
(95% CI) Adjusted HR
(95% CI)
All 1,113 121,460 9.16 1,388 122,346 11.3 1.24 (1.18 to 1.30)
§
1.19 (1.10 to 1.29)
§
Sex
Females 515 58,229 8.84 559 58,329 9.58 1.08 (1.01 to 1.17)
i
1 (Reference)
Males 598 63,231 9.46 829 64,017 13.0 1.37 (1.28 to 1.47)
§
1.22 (1.13 to 1.33)
§
Pfor group ·sex interaction 0.004
Age (years)
40 to 64 868 104,818 8.28 1,069 105,154 10.2 1.23 (1.16 to 1.30)
§
1 (Reference)
65 245 16,642 14.7 319 17,192 18.6 1.26 (1.11 to 1.43)
§
1.16 (1.04 to 1.29)
§
Urbanization
1 (highest) 315 35,713 8.82 535 47,686 11.2 1.27 (1.11 to 1.46)
§
1 (Reference)
2 357 36,299 9.83 460 38,026 12.1 1.23 (1.07 to 1.41)
§
1.06 (0.97 to 1.17)
3 175 21,266 8.23 204 19,042 10.7 1.30 (1.06 to 1.59)
i
0.94 (0.84 to 1.05)
4 (lowest) 266 28,181 9.44 189 17,585 10.8 1.09 (0.98 to 1.21) 0.93 (0.84 to 1.04)
Income (NT$)
<15,840 310 27,714 11.2 379 27,714 13.7 1.22 (1.10 to 1.36)
§
1.18 (1.06 to 1.31)
i
15,841 to 25,000 541 60,930 8.88 496 45,066 11.0 1.24 (1.15 to 1.34)
§
1.09 (0.99 to 1.19)
>25,000 262 32,816 7.98 513 49,566 10.4 1.30 (1.18 to 1.42)
§
1 (Reference)
Comorbidity
Hypertension
No 629 94,663 6.64 788 93,742 8.41 1.27 (1.19 to 1.34)
§
1 (Reference)
Yes 484 26,797 18.1 600 28,604 21.0 1.16 (1.05 to 1.28)
i
2.14 (1.96 to 2.35)
§
Hyperlipidemia
No 815 105,500 7.73 979 101,721 9.62 1.25 (1.18 to 1.32)
§
1 (Reference)
Yes 298 15,960 18.7 409 20,625 19.8 1.06 (0.94 to 1.19) 1.67 (1.53 to 1.84)
§
CAD
No 923 110,175 8.38 1,121 108,056 10.4 1.24 (1.17 to 1.31)
§
1 (Reference)
Yes 190 11,285 16.8 267 14,290 18.7 1.11 (0.96 to 1.28) 1.01 (0.90 to 1.13)
Obesity
No 1,101 120,723 9.12 1,374 121,268 11.3 1.24 (1.19 to 1.30)
§
1 (Reference)
Yes 12 737 16.3 14 1,078 13.0 0.77 (0.49 to 1.21) 0.97 (0.67 to 1.41)
Data for Urbanization representing ‘‘Person-Years’’ cohorts had one patient with missing information in totals.
* Incidence rate, per 1,000 person-years.
†IRR=incident rate ratio.
‡ Adjusted HR =multivariable analysis including sex, age, income, urbanization, and comorbidities of hypertension, CAD, hyperlipidemia, and obesity.
§P<0.01.
iP<0.001.
¶ NT$ =New Taiwan dollars per month. One New Taiwan dollar =US $0.03.
Periodontitis and Risk of Diabetes Volume 85 Number 6
782
studies have yielded apparently conflicting results.
In the first National Health and Nutrition Examina-
tion Survey and its epidemiologic follow-up study,
Demmer et al.
14
found that dentate participants with
severe tooth loss have an odds ratio of 1.7 for incident
diabetes compared with those who have less tooth
loss. Demmer et al.
14
used the periodontal index
21
at
the initial dental surveillance, which could not reflect
tooth mobility, attachment loss, or furcation in-
volvement. The study is limited in its vague method of
assessing periodontitis and inability to exclude un-
diagnosed diabetes at baseline.
14
In contrast, the
study by Ide et al.
15
for Japanese individuals aged 30
to 59 years revealed no apparent association be-
tween periodontal disease and incident diabetes, but
the results of the specific study participants cannot be
generalized to the whole general population. Fur-
thermore, they used the community periodontal in-
dex,
22
which is being questioned as a reliable
epidemiologic tool because of its inability to reflect
the true periodontal status.
23
The present study might provide a way to reconcile
these findings. Because the severity of periodontitis
varied from mild gingivitis to edentulism, the intra-
observer difference and misclassification of peri-
odontitis severity may cause disparity in defining
periodontitis among studies. In addition, periodontitis
is indeed highly prevalent among the adult pop-
ulation. A German dental survey assessed recently
that >70% of adults have periodontitis, and at least
one quarter of them present the severe form.
24
Therapy for periodontitis included systemic, hygiene,
corrective, and supportive treatment.
25
Therefore,
the present study defines only those who received
dental surgery for periodontitis as study participants.
It is reported that 91% of adults in Taiwan were af-
fected with periodontitis;
26
thus, a control group
randomly selected from participants with periodontitis,
matched in 1:1 ratio by sex, age, and index year, was
generated. Based on this study design, a significant
increasing risk of incident diabetes in the study co-
hort was found when compared with the control.
There are several possible explanations and evidence
for the present finding. Chronic inflammation of
periodontitis might represent a triggering factor for
insulin resistance.
27
The inflamed periodontium with
high vascularity might provide an endocrine-like
origin for proinflammatory mediators, such as TNF-
a, IL-6, and IL-1, which are all reported to have
insulin-antagonizing actions.
28
The periodontal
Ta b l e 3 .
HR for Diabetes Compared Between Periodontitis Cohorts With and Without Surgical
Treatment by Follow-Up Duration
Periodontitis Needing Surgical Treatment
No Yes
Follow-up Time (years) Cases Person-Years Rate*Cases Person-Years Rate*IRR
(95% CI) Adjusted HR
(95% CI)
£2(t
1
to t
3
)581 59,194 9.82 750 59,265 12.7 1.29 (1.22 to 1.36)
§
1.23 (1.11 to 1.37)
§
3–5 (t
4
to t
6
) 301 34,493 8.73 351 34,765 10.1 1.16 (1.08 to 1.24)
§
1.12 (0.96 to 1.30)
6–8 (t
7
to t
9
) 149 17,859 8.34 181 18,159 9.97 1.19 (1.09 to 1.31)
§
1.18 (0.95 to 1.46)
>8(>t
9
) 82 9,914 8.27 106 10,158 10.4 1.26 (1.11 to 1.44)
§
1.22 (0.92 to 1.63)
* Incidence rate, per 1,000 person-years.
†IRR=incident rate ratio.
‡ Adjusted HR =multivariable analysis including sex, age income, urbanization, and comorbidities of hypertension, CAD, hyperlipidemia, and obesity.
§P<0.001.
Figure 1.
Cumulative incidence of diabetes compared between periodontitis
cohorts with and without surgical treatment.
J Periodontol June 2014 Lin, Lin, Liu et al.
783
microflora, mostly Gram-negative bacteria, might
generate endotoxemia and further worsen insulin re-
sistance.
28
Pussinen et al.
29
reported that endotoxemia
is associated with an increased risk of incident di-
abetes, and the risk is independent of the metabolic
syndrome.
30
In a subgroup analysis of the Hisayama
study, Saito et al.
31
observed that deep pockets are
related to current and future glucose intolerance. Their
findings suggest that periodontitis might be a risk
factor for DMT2 but failed to confirm this hypothesis in
their study. Furthermore, in an animal model of Zucker
diabetic fatty rats, Watanabe et al.
32
found that peri-
odontitis could accelerate the onset of severe insulin
resistance and DMT2. These studies have clearly
indicated an important relationship between peri-
odontitis and potential glucose intolerance, as well
as diabetes. The present findings that patients with
periodontitis needing dental surgery are at increased
risk of diabetes might reflect that it is the severity of
periodontitis rather than treatment that might be
associated with the development of diabetes. Thus,
it would suggest that preventing worsening of peri-
odontitis severity might lessen the risk of diabetes
in those patients with mild periodontitis. Additional
studies might be needed to investigate this re-
lationship.
The present results also reveal that lower income
at baseline had an HR of 1.18 for incident diabetes.
Therefore, it may be assumed that it is the poverty
that contributes to both the development of peri-
odontitis and diabetes in the present study. It was
stated that low socioeconomic status aggravated
the periodontal condition in individuals with DMT2.
33
Additional attempts are needed to minimize the ef-
fects of socioeconomic disparities on incidence of
diabetes and periodontitis. In another aspect, it was
also found that patients receiving periodontal surgery
indeed were wealthier than the comparison partici-
pants. This might explain why only an association
within 3 years of follow-up was seen, because
wealthier people might receive more medical care
and have their diabetes diagnosed sooner.
34
Furthermore, the present results suggest that in-
creased risk of developing diabetes associated with
severe periodontitis is observed within 2 years (be-
tween time t
1
and time t
3
) after periodontal surgery.
Demmer et al.
14
reported that no dose–response
association could be established between the severity
of periodontitis and risk of future diabetes. The
present result showed that the elevated risk of di-
abetes disappeared after being followed up for
3 years. Because the present study cohort enrolled
only those with the worst periodontal status needing
dental surgery, the excess risk of diabetes between
time t
1
and time t
3
is likely attributable to the pre-
existing glucose intolerance and insulin resistance of
past long-term chronic periodontitis. Conversely,
another explanation for the slightly higher HR is that
some patients with periodontitis have underlying
diabetes without being diagnosed before the index
year, and this would fit the observation that the di-
agnosis of diabetes is higher in the patients with
periodontitis in the short term.
The present study has several limitations that
should be considered when interpreting the results.
First, although the incent diabetes diagnosed within 1
year from baseline was excluded, the causal re-
lationships between periodontitis and subsequent
diabetes could not be confirmed. However, it is noted
that the association between periodontitis needing
surgery and the risk of subsequent diabetes existed
within 3 years of follow-up. Second, there is no
precise information about smoking status, lifestyle,
family history, and body mass index. However, this
situation might happen in both groups. Third, certain
participants were followed for a short observation
period (5.47 3.54 years). However, because the
present findings also indicated the significant effect in
the short period (within 3 years), the short obser-
vation period would further strengthen the present
results. Fourth, there was no precise data about the
severity of periodontitis. However, the dental surgery
for periodontitis in the NHIRD needs strict pre-
operative evaluation and assessment reported in
electronic medical records. The potential for di-
agnostic bias is unlikely. Finally, there are imbal-
ances of comorbidities between the present study
and comparison cohorts. Certain selection bias may
exist, but these confounding factors were adjusted
for. The selection bias would be lessened minimally in
this study. The present study has several strengths.
The comprehensive, detailed, constant, and long-
term follow-up electronic medical records of NHIRD
enable the investigation of a temporal relationship
between periodontitis and diabetes. The nation-
based setting, the universal access to health care,
and the large study size may make the present results
more generalizable and interpretable. Furthermore,
the accuracy of diagnosis based on NHIRD has been
ensured and established.
35,36
CONCLUSIONS
To our knowledge, this is the first nation-based
study demonstrating the chronologic association
between periodontitis and incident diabetes in the
Asian population. Asian diabetes has several unique
characteristics, including a substantial increase of
affected individuals over short periods, relatively
younger onset, and less obesity.
2
There are studies
demonstrating that the diabetes in Asia could be
related to major clinical events, such as cancer,
coronary heart disease, end-stage renal disease, and
Periodontitis and Risk of Diabetes Volume 85 Number 6
784
stroke.
37-39
Considering the huge health conse-
quences and economic impact of the diabetes epi-
demic, several diabetic risks scores have been
proposed.
3,40,41
Strong evidence exists that screening
and lifestyle intervention of high-risk cases for di-
abetes is protective and cost effective.
42
The phe-
nomenon was observed that, within 3 years of follow-
up, the association between periodontitis and the
risk of developing diabetes existed. The present re-
sults may help to early screen and introduce inter-
vention into this potentially high-risk group for future
diabetes.
ACKNOWLEDGMENT
The authors report no conflicts of interest related to
this study.
REFERENCES
1. Wild S, Roglic G, Green A, Sicree R, King H. Global
prevalence of diabetes: Estimates for the year 2000
and projections for 2030. Diabetes Care 2004;27:1047-
1053.
2. Chan JC, Malik V, Jia W, et al. Diabetes in Asia:
Epidemiology, risk factors, and pathophysiology.
JAMA 2009;301:2129-2140.
3. Meigs JB, Shrader P, Sullivan LM, et al. Genotype score
in addition to common risk factors for prediction of
type 2 diabetes. N Engl J Med 2008;359:2208-2219.
4. Talmud PJ, Hingorani AD, Cooper JA, et al. Utility of
genetic and non-genetic risk factors in prediction of
type 2 diabetes: Whitehall II prospective cohort study.
BMJ 2010;340:b4838.
5. Kahn SE, Hull RL, Utzschneider KM. Mechanisms link-
ing obesity to insulin resistance and type 2 diabetes.
Nature 2006;444:840-846.
6. Dandona P, Aljada A, Bandyopadhyay A. Inflamma-
tion: The link between insulin resistance, obesity and
diabetes. Trends Immunol 2004;25:4-7.
7. Spranger J, Kroke A, Mo
¨hlig M, et al. Inflammatory
cytokines and the risk to develop type 2 diabetes:
Results of the prospective population-based European
Prospective Investigation into Cancer and Nutrition
(EPIC)-Potsdam Study. Diabetes 2003;52:812-817.
8. Liu S, Tinker L, Song YQ, et al. A prospective study of
inflammatory cytokines and diabetes mellitus in a mul-
tiethnic cohort of postmenopausal women. Arch Intern
Med 2007;167:1676-1685.
9. Chan KH, Brennan K, You NC, et al. Common varia-
tions in the genes encoding C-reactive protein, tumor
necrosis factor-alpha, and interleukin-6, and the risk of
clinical diabetes in the Women’s Health Initiative
Observational Study. Clin Chem 2011;57:317-325.
10. Laine ML, Crielaard W, Loos BG. Genetic susceptibility
to periodontitis. Periodontol 2000 2012;58:37-68.
11. Redlich K, Smolen JS. Inflammatory bone loss: Path-
ogenesis and therapeutic intervention. Nat Rev Drug
Discov 2012;11:234-250.
12. Jimenez M, Krall EA, Garcia RI, Vokonas PS, Dietrich T.
Periodontitis and incidence of cerebrovascular disease
in men. Ann Neurol 2009;66:505-512.
13. Demmer RT, Molitor JA, Jacobs DR Jr., Michalowicz
BS. Periodontal disease, tooth loss and incident rheu-
matoid arthritis: Results from the First National Health
and Nutrition Examination Survey and its epidemio-
logical follow-up study. J Clin Periodontol 2011;38:
998-1006.
14. Demmer RT, Jacobs DR Jr., Desvarieux M. Periodontal
disease and incident type 2 diabetes: Results from the
First National Health and Nutrition Examination Survey
and its epidemiologic follow-up study. Diabetes Care
2008;31:1373-1379.
15. Ide R, Hoshuyama T, Wilson D, Takahashi K, Higashi T.
Periodontal disease and incident diabetes: A seven-
year study. J Dent Res 2011;90:41-46.
16. Gillies CL, Lambert PC, Abrams KR, et al. Different
strategies for screening and prevention of type 2
diabetes in adults: Cost effectiveness analysis. BMJ
2008;336:1180-1185.
17. Wendt C. Six Countries, Six Reform Models: The
Healthcare Reform Experience of Israel, the Nether-
lands, New Zealand, Singapore, Switzerland and Tai-
wan. Polit Stud Rev 2011;9:254-256.
18. Cha
´varry NG, Vettore MV, Sansone C, Sheiham A. The
relationship between diabetes mellitus and destructive
periodontal disease: A meta-analysis. Oral Health Prev
Dent 2009;7:107-127.
19. Teeuw WJ, Gerdes VE, Loos BG. Effect of periodontal
treatment on glycemic control of diabetic patients: A
systematic review and meta-analysis. Diabetes Care
2010;33:421-427.
20. Lalla E, Papapanou PN. Diabetes mellitus and peri-
odontitis: A tale of two common interrelated diseases.
Nat Rev Endocrinol 2011;7:738-748.
21. Russell AL. A system of classification and scoring for
prevalence surveys of periodontal disease. J Dent Res
1956;35:350-359.
22. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J,
Sardo-Infirri J. Development of the World Health
Organization (WHO) community periodontal index of
treatment needs (CPITN). Int Dent J 1982;32:281-291.
23. Leroy R, Eaton KA, Savage A. Methodological issues in
epidemiological studies of periodontitis — How can it
be improved? BMC Oral Health 2010;10:8.
24. Holtfreter B, Kocher T, Hoffmann T, Desvarieux M,
Micheelis W. Prevalence of periodontal disease and
treatment demands based on a German dental survey
(DMS IV). J Clin Periodontol 2010;37:211-219.
25. Pihlstrom BL. Periodontal risk assessment, diagnosis
and treatment planning. Periodontol 2000 2001;25:
37-58.
26. Lai H, Lo MT, Wang PE, Wang TT, Chen TH, Wu GH. A
community-based epidemiological study of peri-
odontal disease in Keelung, Taiwan: A model from
Keelung community-based integrated screening pro-
gramme (KCIS No. 18). J Clin Periodontol 2007;34:
851-859.
27. Shoelson SE, Lee J, Goldfine AB. Inflammation and
insulin resistance. J Clin Invest 2006;116:1793-1801.
28. Taylor GW, Borgnakke WS. Periodontal disease: As-
sociations with diabetes, glycemic control and compli-
cations. Oral Dis 2008;14:191-203.
29. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS,
Sundvall J, Salomaa V. Endotoxemia, immune re-
sponse to periodontal pathogens, and systemic in-
flammation associate with incident cardiovascular
disease events. Arterioscler Thromb Vasc Biol 2007;
27:1433-1439.
30. Pussinen PJ, Havulinna AS, Lehto M, Sundvall J,
Salomaa V. Endotoxemia is associated with an
J Periodontol June 2014 Lin, Lin, Liu et al.
785
increased risk of incident diabetes. Diabetes Care
2011;34:392-397.
31. Saito T, Shimazaki Y, Kiyohara Y, et al. The severity of
periodontal disease is associated with the development
of glucose intolerance in non-diabetics: The Hisayama
study. J Dent Res 2004;83:485-490.
32. Watanabe K, Petro BJ, Shlimon AE, Unterman TG.
Effect of periodontitis on insulin resistance and the
onset of type 2 diabetes mellitus in Zucker diabetic fatty
rats. J Periodontol 2008;79:1208-1216.
33. Javed F, Na
¨sstro
¨m K, Benchimol D, Altamash M,
Klinge B, Engstro
¨m PE. Comparison of periodontal
and socioeconomic status between subjects with type 2
diabetes mellitus and non-diabetic controls. J Peri-
odontol 2007;78:2112-2119.
34. Szwarcwald CL, Souza-Ju
´nior PR, Damacena GN.
Socioeconomic inequalities in the use of outpatient
services in Brazil according to health care need:
Evidence from the World Health Survey. BMC Health
Serv Res 2010;10:217.
35. Cheng CL, Kao YH, Lin SJ, Lee CH, Lai ML. Validation
of the National Health Insurance Research Database
with ischemic stroke cases in Taiwan. Pharmacoepide-
miol Drug Saf 2011;20:236-242.
36. Yu YB, Gau JP, Liu CY, et al. A nation-wide analysis
of venous thromboembolism in 497,180 cancer pa-
tients with the development and validation of a risk-
stratification scoring system. Thromb Haemost 2012;
108:225-235.
37. Woodward M, Zhang X, Barzi F, et al; Asia Pacific
Cohort Studies Collaboration. The effects of diabetes
on the risks of major cardiovascular diseases and death
in the Asia-Pacific region. Diabetes Care 2003;26:360-
366.
38. So WY, Kong AP, Ma RC, et al. Glomerular filtration
rate, cardiorenal end points, and all-cause mortality
in type 2 diabetic patients. Diabetes Care 2006;29:
2046-2052.
39. Barone BB, Yeh HC, Snyder CF, et al. Long-term all-
cause mortality in cancer patients with preexisting
diabetes mellitus: A systematic review and meta-
analysis. JAMA 2008;300:2754-2764.
40. Aekplakorn W, Bunnag P, Woodward M, et al. A risk
score for predicting incident diabetes in the Thai
population. Diabetes Care 2006;29:1872-1877.
41. Hippisley-Cox J, Coupland C, Robson J, Sheikh A,
Brindle P. Predicting risk of type 2 diabetes in England
and Wales: Prospective derivation and validation of
QDScore. BMJ 2009;338:b880.
42. Bertram MY, Lim SS, Barendregt JJ, Vos T. Assessing
the cost-effectiveness of drug and lifestyle intervention
following opportunistic screening for pre-diabetes in
primary care. Diabetologia 2010;53:875-881.
Correspondence: Dr. Yen-Jung Chang, Department of
Health Promotion and Health Education, National Taiwan
Normal University, 162 He-Ping E. Rd., Sec. 1, Da-An
District, Taipei 106, Taiwan. Fax: 886-2-2363-0326;
e-mail: yjchang2012@gmail.com.
Submitted June 6, 2013; accepted for publication August
21, 2013.
Periodontitis and Risk of Diabetes Volume 85 Number 6
786
... diabetes have focused on the influence of type 2 DM in the development of periodontitis, whereas only a few studies have explored the impact of periodontitis on incident type 2 DM(Chiu et al., 2015;Demmer et al., 2008;Ide et al., 2011;Lin et al., 2014;Morita et al., 2012;Saito et al., 2004). The overall available evidence, summarized for the Workshop of the IDF and the European Federation of Periodontology (EFP), reported that individuals affected by periodontitis had a higher probability to develop type 2 DM when compared with non-periodontitis subjects, with a hazard ratio (HR) between 1.2 and 1.3(Graziani et al., 2018). ...
... p < .001). The different estimates between this study and others(Chiu et al., 2015;Ide et al., 2011;Lin et al., 2014;Morita et al., 2012;Saito et al., 2004) may be due to the differences in the prevalence of diabetes in Japan and Taiwan (<8.0%) versus Spain (13.8%) (International Diabetes Federation, 2021). ...
Article
Aim To evaluate the cross‐sectional association between severe periodontitis and diabetes mellitus (DM), in a representative sample of Spanish population. Materials and Methods The di@bet.es epidemiological study is a population‐based cohort study aimed to determine the prevalence and incidence of DM in the adult population of Spain. The at‐risk sample at the final examination (2016–2017) included 1751 subjects who completed an oral health questionnaire. This questionnaire, together with demographic and risk factors, had been previously validated to build an algorithm to predict severe periodontitis in the Spanish population. Logistic regression models were used to evaluate the association between severe periodontitis and DM with adjustment for confounding factors. Results In total, 144 subjects developed DM, which yielded 8.2% cumulative incidence. Severe periodontitis was detected in 59.0%, 54.7% or 68.8% of the subjects depending on three different selected criteria at the 2016–2017 exam. All criteria used to define severe periodontitis were associated with DM in unadjusted analysis, but the magnitude of the association decreased after adjusting for significant confounders. The criteria ‘≥50% of teeth with clinical attachment loss ≥5 mm’ presented an odds ratio of 4.9 (95% confidence interval: 2.2–10.7; p ≤ .001) for DM. Conclusions Severe periodontitis is associated with DM in the Spanish population.
... Not only is periodontitis a risk for difficult glycemic control, but it is also a complication of diabetes mellitus, resulting in a "bidirectional association" between them [7]. Periodontal disease affects glycemic control and increases the risk of developing hyperglycemia, which increases with periodontal disease severity [8][9][10][11]. Some evidence suggests that the treatment of periodontal disease would result in better glycemic control [12]. For coronary heart disease and atherosclerosis, patients with periodontal disease are at an increased risk for these diseases, including acute myocardial infarctions [13]. ...
... Each disease will adversely affect the other in this relationship. Periodontal disease association with diabetes mellitus is probably the most established bidirectional relationship, with periodontal disease affecting glycemic control [8], and individuals with periodontal disease have 19-33% more risk of developing hyperglycemia [9,10], which is increased with periodontal disease severity [11]. On the other hand, having diabetes mellitus is associated with three-times increased risk of having periodontal disease [30]. ...
Article
Full-text available
Periodontal disease is associated with other non-communicable diseases including diabetes mellitus, coronary heart disease and atherosclerosis, hypertension, and respiratory tract infections. This association merits careful study of the general population’s awareness level in order to leverage the current state of science to improve general health and quality of life. This study included 502 residents of Saudi Arabia who received computer-assisted interviews to fill up the survey. Results indicated a low level of awareness among the study population regarding the association of periodontal disease to diabetes mellitus, coronary heart disease and atherosclerosis, hypertension, and respiratory tract infections. A higher level of awareness was noticed with individuals with periodontal disease, themselves or a member of their family having a systemic disease, and who have a specialized person or scientific article as their source of information. This observed low level of awareness deserves the attention of public health authorities to prioritize programs that increase the awareness, improve health, and reduce burden of systemic diseases of high prevalence, morbidity, and mortality.
... Gingivitis and periodontitis are examples of bacterial infection that predispose to diabetes [36]. These infections are associated with local and systemic inflammatory responses that may adversely affect glycaemic levels [37] and increase the risk of diabetes [38,39]. ...
Article
Full-text available
An association between diabetes and infection has been recognised for many years, with infection being an important cause of death and morbidity in people with diabetes. The COVID-19 pandemic has re-kindled an interest in the complex relationship between diabetes and infection. Some infections occur almost exclusively in people with diabetes, often with high mortality rates without early diagnosis and treatment. However, more commonly, diabetes is a complicating factor in many infections. A reciprocal relationship occurs whereby certain infections and their treatments may also increase the risk of diabetes. People with diabetes have a 1.5- to 4-fold increased risk of infection. The risks are the most pronounced for kidney infection, osteomyelitis and foot infection, but are also increased for pneumonia, influenza, tuberculosis, skin infection and general sepsis. Outcomes from infection are worse in people with diabetes, with the most notable example being a twofold higher rate of death from COVID-19. Hyperglycaemia has deleterious effects on the immune response. Vascular insufficiency and neuropathy, together with altered skin, mucosal and gut microbial colonisation, contribute to the increased risk of infection. Vaccination is important in people with diabetes although the efficacy of certain immunisations may be compromised, particularly in the presence of hyperglycaemia. The principles of treatment largely follow those of the general population with certain notable exceptions. Graphical Abstract
... Prospective cohort studies have shown that untreated patients with periodontitis can also present with decreased serum levels of glucagon-like peptide-1 (GLP-1) compared with healthy periodontal controls. 14 Periodontitis patients exhibited a 33% increased risk of hyperglycemia 15 and a 1.24-fold increased risk of developing T2D 16 after >5 years of follow-up. In addition, patients with T2D and periodontitis showed significantly higher FBG levels, increased homeostasis model assessments of IR (HOMA-IR) levels, 11,17 and decreased homeostasis model assessment of β-cell function (HOMA-β) levels, 18 suggesting that periodontitis exacerbates β-cell dysfunction and peripheral IR in T2D patients. ...
Article
Full-text available
Periodontitis is an infectious disease caused by an imbalance between the local microbiota and host immune response. Epidemiologically, periodontitis is closely related to the occurrence, development, and poor prognosis of T2D and is recognized as a potential risk factor for T2D. In recent years, increasing attention has been given to the role of the virulence factors produced by disorders of the subgingival microbiota in the pathological mechanism of T2D, including islet β-cell dysfunction and insulin resistance (IR). However, the related mechanisms have not been well summarized. This review highlights periodontitis-derived virulence factors, reviews how these stimuli directly or indirectly regulate islet β-cell dysfunction. The mechanisms by which IR is induced in insulin-targeting tissues (the liver, visceral adipose tissue, and skeletal muscle) are explained, clarifying the influence of periodontitis on the occurrence and development of T2D. In addition, the positive effects of periodontal therapy on T2D are overviewed. Finally, the limitations and prospects of the current research are discussed. In summary, periodontitis is worthy of attention as a promoting factor of T2D. Understanding on the effect of disseminated periodontitis-derived virulence factors on the T2D-related tissues and cells may provide new treatment options for reducing the risk of T2D associated with periodontitis.
... 18 Individuals with periodontal disease exhibited poorer glycaemic control and have 19-33% higher risk of developing diabetes, 19 with the highest incidence reported in those with severe periodontal disease. 20,21 Also, presence of periodontal disease has been found to increase the risk of T2DM complications, such as macroalbuminuria, end-stage renal disease and cardiorenal mortality (ischaemic heart disease and diabetic nephropathy combined), by 2-3 times. 18 Conversely, T2DM also increases the risk of periodontal disease by 2-3 times, with a clear link between the degree of hyperglycaemia, and the onset, extent and severity of periodontal disease. ...
Article
Introduction: Chronic periodontal disease is a highly prevalent dental condition affecting tooth-supporting tissues. Scientific evidence is accumulating on links between periodontal disease and various systemic conditions. This narrative review provides a holistic yet succinct overview that would assist medical practitioners to deliver integrated care for better clinical outcomes. Method: Scientific evidence on associations between periodontal disease and systemic conditions was synthesised and critically appraised. Key findings of latest prospective cohort studies, randomised clinical trials, and meta-analysis were closely assessed and compiled. Results: A bidirectional relationship has been established, indicating that diabetes and periodontal disease are closely linked and amplify one another, if not successfully controlled. Existing evidence also supports the associations of periodontal disease with cardiovascular diseases and adverse pregnancy outcomes. Successful treatment of periodontal disease and dental prophylaxis has been shown to improve clinical outcomes in these systemic conditions. Other systemic conditions associated with periodontal disease include respiratory diseases, Alzheimer's disease, rheumatoid arthritis and chronic kidney disease. Although the underlying mechanisms remain to be fully elucidated, it is generally accepted that the inflammatory burden of chronic periodontal disease has an important systemic impact. Conclusion: Oral-systemic links are multifaceted and complex. While evidence linking periodontal disease with a variety of systemic conditions is still emerging, the nature of the relationship is becoming clearer. The updated understanding of these associations warrants the attention of medical experts and policymakers for a concerted effort to develop a patient-centric, integrated model for the treatment of comorbid dental and medical conditions.
Article
Aim We investigated whether periodontal measures are cross‐sectionally associated with prediabetes and cardiometabolic biomarkers among non‐diabetic younger adults. Materials and Methods One thousand seventy‐one participants (mean age = 32.2 years [SE = 0.3]; 73% female) from the Oral Infections, Glucose Intolerance and Insulin Resistance Study were enrolled. Full‐mouth clinical attachment loss (fm‐CAL), probing depth (fm‐PD) and bleeding on probing were ascertained. Interproximal CAL (i‐CAL) and probing depths (i‐PD) served as our primary exposures. Glucose, HbA1c, insulin and insulin resistance (HOMA‐IR) outcomes were assessed from fasting blood. Prediabetes was defined per American Diabetes Association guidelines. Prediabetes prevalence ratios (PR [95% CI]) and mean [SE] cardiometabolic biomarkers were regressed on periodontal variables via multivariable robust variance Poisson regression or multivariable linear regression. Results Prevalence of prediabetes was 12.5%. Fully adjusted prediabetes PR in Tertiles 3 versus 1 of mean i‐CAL was 2.42 (1.77, 3.08). Fully adjusted fasting glucose estimates across i‐CAL tertiles were 83.29 [0.43], 84.31 [0.37], 86.48 [0.46]; p for trend <.01. Greater percent of sites with i‐PD ≥3 mm showed elevated natural‐log‐HOMA‐IR after adjustment (0%–12% of sites = 0.33 [0.03], 13%–26% of sites = 0.39 [0.03], ≥27% of sites = 0.42 [0.03]; p for trend = .04). Conclusions i‐CAL (vs. fm‐CAL) was associated with elevated fasting glucose and prediabetes, whereas i‐PD (vs. fm‐PD) was associated with insulin resistance. Future studies are needed to examine periodontal disease and incident prediabetes.
Chapter
This chapter deals with the association of diabetes with various oral diseases, including gingivitis, periodontitis, caries, hyposalivation, candidal infection, and cancer. The incidence of gingivitis is particularly high in children and adolescents with newly discovered type 1 diabetes, and in individuals with diabetes with glycated haemoglobin values above 10%. The role of neutrophils in the development of periodontitis in general is considered protective, and impaired neutrophil function may account for an increased susceptibility to periodontitis. Indeed, neutrophil function in individuals with diabetes and periodontitis has been studied intensively. A model-based cost-effectiveness analysis of periodontal treatment among individuals with type 2 diabetes has shown that providing non-surgical periodontal treatment for people with type 2 diabetes and periodontitis would likely have meaningful public health benefits. In the oral cavity various types of malignancy may occur, with squamous cell carcinoma accounting for the vast majority.
Article
Objective: Two-way relationship between periodontitis and diabetes was advocated. However, bidirectional epidemiological observation is still limited and inconsistent. Using the National Health Insurance Research Database of Taiwan (covering over 99% of the entire population), we estimate the development of diabetes in periodontitis patients or that of periodontitis in patients with type 2 diabetes mellitus (T2DM), respectively. Methods: A total of 11,011 patients with severe periodontitis were recruited from 2000 to 2015. After matching by age, sex, and index date, 11,011 patients with mild periodontitis and 11,011 non-periodontitis controls were registered. Conversely, 157,798 patients with T2DM and 157,798 non-T2DM controls were enrolled, whereas the development of periodontitis was traced. Cox proportional hazards model was performed. Results: Periodontitis patients tended to have a statistically high risk of having T2DM. Adjusted hazard ratio (aHR) was 1.94 (95% CI 1.49-2.63, p < 0.01) and 1.72 (95% CI 1.24-2.52, p < 0.01) for severe and mild periodontitis groups, respectively. Besides, the patients in severe periodontitis had a high risk of having T2DM compared to that in mild periodontitis [1.17 (95% CI 1.04-1.26, p < 0.001)]. Conversely, the risk of periodontitis increased significantly in patients with T2DM [1.99 (95% CI,1.42-2.48, p < 0.01)]. However, the high risk was observed for the outcome of severe periodontitis [2.08 (95% CI, 1.50-2.66, p < 0.001)], not for that of mild periodontitis [0.97 (95% CI,0.38-1.57, p = 0.462)]. Conclusions: We suggested the bi-direction is between T2DM and severe periodontitis, but not in mild type.
Preprint
Full-text available
Two-way relationship between periodontitis and diabetes was advocated; however, bidirectional observation in general population is still inconclusive. Using the Taiwan Health Insurance Database (covering over 99% of the entire population),11,011 patients with severe periodontitis were recruited from 2000 to 2015.After matching by age, sex, and index date, 11,011 patients with mild periodontitis and 11,011 non-periodontitis controls were registered. The outcome of T2DM was traced. Conversely, the development of periodontitis was traced in 157,798 patients with T2DM, and 157,798 non-diabetic controls enrolled. The risks of T2DM significantly increased in groups with severe and mild periodontitis, with the adjusted hazard ratio (aHR) and 95% confidence interval (CI) being 1.94 (1.49–2.63, p < 0.01) and 1.72 (1.24–2.52, p < 0.01), respectively. Patients with severe periodontitis had a high risk of having diabetes compared to those with mild periodontitis [aHR, 1.17 (95% CI 1.04–1.26, p < 0.001)]. Conversely, the risk of periodontitis increased significantly in patients with T2DM [1.99 (1.42–2.48, p < 0.01)]. However, the high risk was not observed for the outcome of mild periodontitis [0.97 (0.38–1.57, p = 0.462)]. We, therefore, suggested the bi-direction is between diabetes and severe periodontitis, but not in mild type.
Article
Introduction: The aim of this review is to examine and quantify the long-term risk of immune-mediated systemic conditions in people with periodontitis compared to people without periodontitis. Methods: Medline, EMBASE and Cochrane databases were searched up to June 2022 using keywords and MeSH headings. The 'Risk of Bias in Non-Randomised Studies of Interventions' tool was used to assess bias. Cohort studies comparing incident metabolic/autoimmune/inflammatory diseases in periodontitis to healthy controls were included. Meta-analysis and meta-regression quantified risks and showed impact of periodontitis diagnosis type and severity. Results: The search retrieved 3354 studies; 166 studies were eligible for full-text screening, and 30 studies were included for review. Twenty-seven studies were eligible for meta-analysis. The risks of diabetes, rheumatoid arthritis (RA) and osteoporosis were increased in people with periodontitis compared to without periodontitis (diabetes-relative risk [RR]: 1.22, 95% CI: 1.13-1.33; RA-RR: 1.27, 95% CI: 1.07-1.52; osteoporosis-RR: 1.40, 95% CI: 1.12-1.75). Risk of diabetes showed gradient increase by periodontitis severity (moderate-RR = 1.20, 95% CI = 1.11-1.31; severe-RR = 1.34, 95% CI = 1.10-1.63). Conclusion: People with moderate-to-severe cases of periodontitis have the highest risk of developing diabetes, while the effect of periodontal severity on risk of other immune-mediated systemic conditions requires further investigation. More homologous evidence is required to form robust conclusions regarding periodontitis-multimorbidity associations.
Book
Full-text available
This book brings together the writings of experts on the health care reforms of six small open economies in different continents that engaged in extensive health reform debates in the 1980s and 1990s. While facing similar challenges and demographic pressures and changing consumer demands, and while discussing a similar range of policy options, the final outcomes of the reform debates were strikingly dissimilar. Each nation choose its own reform pathway and that choice had more to do with the country-specific constellation of ideas, interests and institutions than the given set of problems and reform pressures. The selection of the relatively small nations offers a rich menu of health reform experiences across the globe, experiences that often remain 'under the radar screen' as most comparative studies seem to focus on the major industrial countries.
Article
Full-text available
With increasing globalization and East-West exchanges, the increasing epidemic of type 2 diabetes in Asia has far-reaching public health and socioeconomic implications. To review recent data in epidemiologic trends, risk factors, and complications of type 2 diabetes in Asia. Search of MEDLINE using the term diabetes and other relevant keywords to identify meta-analyses, systematic reviews, large surveys, and cohort studies. Separate searches were performed for specific Asian countries. The review was limited to English-language articles published between January 1980 and March 2009; publications on type 1 diabetes were excluded. The prevalence of diabetes in Asian populations has increased rapidly in recent decades. In 2007, more than 110 million individuals in Asia were living with diabetes, with a disproportionate burden among the young and middle aged. Similarly, rates of overweight and obesity are increasing sharply, driven by economic development, nutrition transition, and increasingly sedentary lifestyles. The "metabolically obese" phenotype (ie, normal body weight with increased abdominal adiposity) is common in Asian populations. The increased risk of gestational diabetes, combined with exposure to poor nutrition in utero and overnutrition in later life in some populations, may contribute to the increasing diabetes epidemic through "diabetes begetting diabetes" in Asia. While young age of onset and long disease duration place Asian patients with diabetes at high risk for cardiorenal complications, cancer is emerging as an important cause of morbidity and mortality. Type 2 diabetes is an increasing epidemic in Asia, characterized by rapid rates of increase over short periods and onset at a relatively young age and low body mass index. Prevention and control of diabetes should be a top public health priority in Asian populations.
Article
Recent data have revealed that the plasma concentration of inflammatory mediators, such as tumour necrosis factor-α (TNF-α) and interleukin-6 (IL-6), is increased in the insulin resistant states of obesity and type 2 diabetes, raising questions about the mechanisms underlying inflammation in these two conditions. It is also intriguing that an increase in inflammatory mediators or indices predicts the future development of obesity and diabetes. Two mechanisms might be involved in the pathogenesis of inflammation. Firstly, glucose and macronutrient intake causes oxidative stress and inflammatory changes. Chronic overnutrition (obesity) might thus be a proinflammatory state with oxidative stress. Secondly, the increased concentrations of TNF-α and IL-6, associated with obesity and type 2 diabetes, might interfere with insulin action by suppressing insulin signal transduction. This might interfere with the anti-inflammatory effect of insulin, which in turn might promote inflammation.
Article
Background To contain cost, Taiwan's previous National Health Insurance Reimbursement Policy requested that physicians discontinue their patients' statin therapy once the serum cholesterol had reached appropriate levels. This allowed us to evaluate the association between statin continuation and the occurrence of atrial fibrillation/flutter and whether it was modified by chronic kidney disease (CKD) status. Methods Patients who initiated statin therapy between January 1, 2001 and December 31, 2009 were identified from a random sample of one million subjects in the Taiwan National Health Insurance Research Database. The outcome was atrial fibrillation/flutter. A proportional hazard regression model with time-varying statin use was applied to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) for atrial fibrillation/flutter according to current statin use versus treatment discontinuation, adjusted for baseline disease risk scores and time-varying covariates. Results A total of 6767 CKD and 63,678 non-CKD patients initiating statin therapy were included and followed for an average of 4.0 years. A total of 1118 participants experienced new-onset atrial fibrillation/flutter. The incidence of atrial fibrillation/flutter was approximately 2 fold higher in the CKD patients. Continuation of statin therapy was associated with a 22% (adjusted hazard ratio 0.78; 95% CI: 0.65–0.93) and 57% (adjusted HR 0.43; 95% CI: 0.27–0.68) decrease in atrial fibrillation/flutter hazard as compared with discontinuation in non-CKD and CKD patients, respectively. Conclusions Continuation of statin therapy was associated with a decreased risk of atrial fibrillation/flutter among CKD and non-CKD patients. However, further randomized studies are still needed to assess the association.
Article
The Asian population is thought to have a low risk of venous thromboembolism (VTE), but the epidemiology of VTE in cancer patients remains unclear. The National Health Insurance Research Database of Taiwan was used to find hospitalised patients newly-diagnosed with cancer to determine the incidence of VTE in cancer patients and to identify the risk factors for VTE. Between 1997 and 2005, 497,180 cancer patients were identified. During a median follow-up of 21.3 months (range 0–119.9 months), 5,296 patients developed VTE. The estimated incidence was 185 events per 100,000 person-years. Patients with a prior history of VTE and female patients between the ages of 40 and 80 carried high risk of VTE. The rate of VTE was relatively high in patients with myeloma, prostate cancer, lung cancer, gynaecologic cancers, sarcoma, and metastasis of unknown origin. We developed a risk-stratification scoring system to divide the cancer patients into four discrete risk groups (very low risk, low risk, intermediate, and high risk). The incidence of VTE in each group was 0.5%, 0.9%, 1.5%, and 8.7%, respectively (p < 0.001). This scoring system was validated in a separate patient cohort. In conclusion, VTE is a distinct burden for cancer patients in Taiwan. The risk scoring system could prove helpful in decision-making concerning thromboprophylaxis in cancer patients. Note: The results of this paper were presented as an Asian-Pacific Scholarship Award at the 23rd Congress of the International Society on Thrombosis and Haemostasis, Kyoto, Japan, 23–28 July 2011.
Article
Bone is a tissue undergoing continuous building and degradation. This remodelling is a tightly regulated process that can be disturbed by many factors, particularly hormonal changes. Chronic inflammation can also perturb bone metabolism and promote increased bone loss. Inflammatory diseases can arise all over the body, including in the musculoskeletal system (for example, rheumatoid arthritis), the intestine (for example, inflammatory bowel disease), the oral cavity (for example, periodontitis) and the lung (for example, cystic fibrosis). Wherever inflammatory diseases occur, systemic effects on bone will ensue, as well as increased fracture risk. Here, we discuss the cellular and signalling pathways underlying, and strategies for therapeutically interfering with, the inflammatory loss of bone.
Article
In this systematic review, we explore and summarize the peer-reviewed literature on putative genetic risk factors for susceptibility to aggressive and chronic periodontitis. A comprehensive literature search on the PubMed database was performed using the keywords 'periodontitis' or 'periodontal disease' in combination with the words 'genes', 'mutation', 'SNP' or 'polymorphism'. The studies selected were written in English, had a case-control design, and reported genotype distribution. Only studies with at least 100 individuals in either the case or control group were included. Research on genetic polymorphisms has only had limited success in identifying significant and reproducible genetic factors for susceptibility to aggressive periodontitis and chronic periodontitis. Taking together the data published on gene polymorphisms in aggressive and chronic periodontitis, we conclude that there are differences among the various studies for the rare allele carriage rates. Nevertheless, there is some evidence that polymorphisms in the IL1B, IL1RN, FcγRIIIb, VDR and TLR4 genes may be associated with aggressive periodontitis susceptibility, and polymorphisms in the IL1B, IL1RN, IL6, IL10, VDR, CD14, TLR4 and MMP1 genes may be associated with chronic periodontitis susceptibility as a single genetic factor in certain populations. Future studies should apply stricter disease classifications, use larger study cohorts, adjust for relevant risk factors in aggressive and chronic periodontiti,s and include analysis of multiple genes and polymorphisms. Establishing consortia and performing collaborative studies may help to conquer the limitations of small sample size and limited statistical power.
Article
Infection may be a rheumatoid arthritis (RA) risk factor. We examined whether signs of periodontal infection were associated with RA development in the First National Health and Nutrition Examination Survey and its epidemiological follow-up study. In 1971-1974, 9702 men and women aged 25-74 were enrolled and surveyed longitudinally (1982, 1986, 1987, 1992). Periodontal infection was defined by baseline tooth loss or clinical evidence of periodontal disease. Baseline (n = 138) and incident (n = 433) RA cases were defined via self-report physician diagnosis, joint pain/swelling, ICD-9 codes (714.0-714.9), death certificates and/or RA hospitalization. Adjusted odds ratios (ORs) (95% CI) for prevalent RA in gingivitis and periodontitis (versus healthy) were 1.09 (0.57, 2.10) and 1.85 (0.95, 3.63); incident RA ORs were 1.32 (0.85, 2.06) and 1.00 (0.68, 1.48). The ORs for prevalent RA among participants missing 5-8, 9-14, 15-31 or 32 teeth (versus 0-4 teeth) were 1.74 (1.03, 2.95), 1.82 (0.81, 4.10), 1.45 (0.62, 3.41) and 1.30 (0.48, 3.53); ORs for incident RA were 1.12 (0.77, 1.64), 1.67 (1.12, 2.48), 1.40 (0.85, 2.33) and 1.22 (0.75, 2.00). Dose-responsiveness was enhanced among never smokers. The rate of death or loss-to-follow-up after 1982 was two- to fourfold higher among participants with periodontitis or missing ≥9 teeth (versus healthy participants). Although participants with periodontal disease or ≥5 missing teeth experienced higher odds of prevalent/incident RA, most ORs were non-statistically significant and lacked dose-responsiveness. Differential RA ascertainment bias complicated the interpretation of these data.
Article
Diabetes mellitus (a group of metabolic disorders characterized by hyperglycemia) and periodontitis (a microbially induced inflammatory disorder that affects the supporting structures of teeth) are both common, chronic conditions. Multiple studies have demonstrated that diabetes mellitus (type 1 and type 2) is an established risk factor for periodontitis. Findings from mechanistic studies indicate that diabetes mellitus leads to a hyperinflammatory response to the periodontal microbiota and also impairs resolution of inflammation and repair, which leads to accelerated periodontal destruction. The cell surface receptor for advanced glycation end products and its ligands are expressed in the periodontium of individuals with diabetes mellitus and seem to mediate these processes. The association between the two diseases is bidirectional, as periodontitis has been reported to adversely affect glycemic control in patients with diabetes mellitus and to contribute to the development of diabetic complications. In addition, meta-analyses conclude that periodontal therapy in individuals with diabetes mellitus can result in a modest improvement of glycemic control. The effect of periodontal infections on diabetes mellitus is potentially explained by the resulting increase in levels of systemic proinflammatory mediators, which exacerbates insulin resistance. As our understanding of the relationship between diabetes mellitus and periodontitis deepens, increased patient awareness of the link between diabetes mellitus and oral health and collaboration among medical and dental professionals for the management of affected individuals become increasingly important.